SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-004501
Filing Date
2024-06-26
Accepted
2024-06-26 17:25:15
Documents
19
Period of Report
2024-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm   iXBRL 8-K 39326
2 FORM OF COMMON WARRANT cns_ex0401.htm EX-4.1 109533
3 ARENTFOX SCHIFF LLP LEGAL OPINION cns_ex0501.htm EX-5.1 13803
4 FORM OF SECURITIES PURCHASE AGREEMENT cns_ex1001.htm EX-10.1 294369
5 FINANCIAL ADVISORY AGREEMENT BETWEEN CNS PHARMACEUTICALS, INC. AND A.G.P./ALLIAN cns_ex1002.htm EX-10.2 46683
6 PRESS RELEASE DATED JUNE 26, 2024 cns_ex9901.htm EX-99.1 9239
10 GRAPHIC image_001.jpg GRAPHIC 6363
  Complete submission text file 0001683168-24-004501.txt   810837

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cnsp-20240626.xsd EX-101.SCH 3018
8 XBRL LABEL FILE cnsp-20240626_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE cnsp-20240626_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3802
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 241074632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)